Analyzing...
Loading company...
Max Healthcare Institute Ltd. engages in the management and operation of hospitals and specialty clinics. The firm operates through the Medical and Healthcare Services segment. The firm also operates a homecare business and pathology business under the brand names Max@Home and Max Lab. Max@Home offers health and wellness services at home. Max Lab provides pathology services outside its hospital network. The firm is specialized in providing treatment for cancer care/oncology, cardiac sciences, endocrinology and diabetes, eye care/ophthalmology, gastroenterology, hepatology and endoscopy, laparoscopic/minimal access surgery, neurosciences, liver transplant and biliary sciences, orthopedics and joint replacement, bariatric surgery/metabolic, robotic surgery, kidney transplant, bone marrow transplant, urology, and vascular surgery. The firm owns, operates and provides medical services to facilities in Delhi, Mumbai, Punjab, Uttar Pradesh and Uttarakhand. The company has approximately 17 healthcare facilities.
No significant concerns identified
Nothing flagged for monitoring
“Services business in Healthcare — Hospitals & Diagnostics.”
₹8,373 Cr service revenue.
Employee costs at 16.2% of revenue — primary cost driver.
“Network gross revenue stood at INR 2,608”
“never given a guidance on, forward looking numbers.”
“Revenue increased by 10% year on year”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 13.4%▲ | 9.0% |
| ROCE | 12.7%▲ | 10.4% |
| Net Margin | 16.9%▲ | 8.5% |
| EBITDA Margin | 27.6%▲ | 20.6% |
| Debt To Equity | 0.32x▲ | 0.16x |
| Rev Growth 3yr | 22.0%▲ | 14.4% |
| EPS Growth 3yr | 9.2%▼ | 9.9% |
| Employee Cost Ratio | 16.20x | - |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | ₹8,373 Cr +19.1% | ₹7,028 Cr +30.0% | ₹5,406 Cr +18.5% | ₹4,563 Cr +16.1% | ₹3,931 Cr +57.0% | ₹2,505 Cr |
| Other Income | ₹163 Cr +4.5% | ₹156 Cr -12.6% | ₹178 Cr +27.9% | ₹139 Cr +9.3% | ₹127 Cr +11.0% | ₹115 Cr |
| Total Income | ₹8,536 Cr +18.8% | ₹7,184 Cr +28.7% | ₹5,584 Cr +18.8% | ₹4,702 Cr +15.8% | ₹4,059 Cr +55.0% | ₹2,619 Cr |
| COGS | ₹1,790 Cr +21.2% | ₹1,477 Cr +32.1% | ₹1,119 Cr +21.3% | ₹922 Cr -0.1% | ₹923 Cr +55.3% | ₹594 Cr |
| ₹6,812 Cr +19.4% | ₹5,704 Cr +35.2% | ₹4,219 Cr +16.0% | ₹3,638 Cr +9.9% | ₹3,311 Cr +34.9% | ₹2,454 Cr | |
| Profit Before Tax | ₹1,676 Cr +19.1% | ₹1,406 Cr +3.0% | ₹1,365 Cr +28.4% | ₹1,064 Cr +44.0% | ₹739 Cr ↑ Recovery | (₹69 Cr) |
| Exceptional Items | (₹48 Cr) +34.5% | (₹74 Cr) | ₹0.00 Cr | ₹0.00 Cr +100.0% | (₹9 Cr) +96.1% | (₹234 Cr) |
| ₹233 Cr -29.4% | ₹330 Cr +7.4% | ₹308 Cr ↑ Recovery | (₹40 Cr) ↓ Decline | ₹134 Cr +191.9% | ₹46 Cr | |
| Net Profit | ₹1,442 Cr +34.1% | ₹1,076 Cr +1.7% | ₹1,058 Cr -4.2% | ₹1,104 Cr +82.4% | ₹605 Cr ↑ Recovery | (₹138 Cr) |
| Profit (Owners) | ₹1,442 Cr +34.1% | ₹1,076 Cr +1.7% | ₹1,058 Cr -4.2% | ₹1,104 Cr +82.4% | ₹605 Cr ↑ Recovery | (₹137 Cr) |
| Other Comprehensive Income | (₹2 Cr) +65.3% | (₹5 Cr) +29.5% | (₹6 Cr) | (₹0.48 Cr) ↓ Decline | ₹3 Cr +419.6% | ₹0.51 Cr |
| EPS | ₹14.83 | ₹11.07 | ₹10.88 | ₹11.37 | ₹6.24 | (₹1.42) |
| Diluted Shares | ₹97 Cr | ₹97 Cr | ₹97 Cr | ₹97 Cr | ₹97 Cr | ₹97 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Max Healthcare Institute Limited has submitted the Exchange a copy Scrutinizer's report of 25th Annual General Meeting held on July 30, 2026. Further, the Company has informed the Exchange regarding v...
Max Healthcare Institute Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 30, 2026
Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Max Healthcare Institute Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Max Healthcare Institute Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for the financial year 2025-26'.
Max Healthcare Institute Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 30, 2026
Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Max Healthcare Institute Limited has informed the Exchange about disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Abhay Soi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Max Healthcare Institute Limited has informed the Exchange about construction of Phase-I of Max Super Specialty Hospital, Shaheed Path, Lucknow
Max Healthcare Institute Limited has informed the Exchange regarding ' approval of re-classification of Radiant Life Care Hospital Foundation from Promoter Group to Public category'.
Max Healthcare Institute Limited has informed the Exchange regarding Change in Director(s) of the company.
Max Healthcare Institute Limited has informed the Exchange regarding change in Registered Office of the company from State of Maharashtra to State of Haryana.
Max Healthcare Institute Limited has informed the Exchange regarding Change in Auditors of the company.
Max Healthcare Institute Limited has informed the Exchange about Presentation on Earnings Update for the quarter and financial year ended March 31, 2026